ENZON PHARMACEUTICALS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Enzon Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Enzon Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $254K, a 20.9% decline year-over-year.
  • Enzon Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $1.52M, a 47.2% increase year-over-year.
  • Enzon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $1.37M.
  • Enzon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$186K, a 60.3% increase from 2021.
  • Enzon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$469K, a 64.2% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.37M +$1.56M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 -$186K +$283K +60.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 -$469K +$842K +64.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-16
2020 -$1.31M -$332K -33.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
2019 -$979K -$6.83M -117% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-23
2018 $5.85M +$404K +7.42% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-19
2017 $5.45M +$6.57M Jan 1, 2017 Dec 31, 2017 10-K 2019-02-21
2016 -$1.13M -$22.8M -105% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-21
2015 $21.6M -$7.16M -24.9% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-24
2014 $28.8M +$10.6M +58.7% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-21
2013 $18.2M +$20.9M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-05
2012 -$2.78M +$18M +86.6% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-14
2011 -$20.8M -$198M -112% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 $177M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.